Afoxolaner 9.375Mg / Moxidectin 45Mcg / Pyrantel 18.75Mg Chewable Tablet
261 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
261
Total Reports
5
Deaths Reported
190.0%
Death Rate
Active Ingredients
Afoxolaner 9.375Mg / Moxidectin 45Mcg / Pyrantel 18.75Mg Chewable Tablet
Administration Routes
OralUnknownTopical
Species Affected
Dog 239
Unknown 21
Human 1
Most Affected Breeds
Chihuahua 35
Terrier - Yorkshire 32
Dog (unknown) 29
Unknown 22
Beagle 21
Maltese 17
Poodle - Toy 10
Spitz - German Pomeranian 9
Poodle - Miniature 8
Dachshund (unspecified) 8
Most Reported Reactions
Vomiting 70
Diarrhoea 34
Lethargy (see also Central nervous system depression in Neurological) 33
Lack of efficacy (ectoparasite) - flea 18
Lack of efficacy (endoparasite) - roundworm NOS 15
Not eating 13
Tablets, Abnormal 12
Seizure NOS 11
Lack of efficacy (bacteria) - Borrelia 10
Lack of efficacy (endoparasite) - tapeworm 9
Decreased appetite 9
Shaking 8
Outcome Breakdown
Outcome Unknown
115 (47.9%)
Recovered/Normal
97 (40.4%)
Ongoing
23 (9.6%)
Died
3 (1.3%)
Euthanized
2 (0.8%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.